| Biotechnology Industry | Healthcare Sector | Mr. Jie Zhang CEO | SSE Exchange | CNE1000041S6 ISIN |
| CN Country | 476 Employees | 24 Jun 2021 Last Dividend | - Last Split | - IPO Date |
Jiangsu Aidea Pharmaceutical Co., Ltd. is a pharmaceutical company founded in 2009, focused on the development, production, and sale of pharmaceutical products. The company is located in Yangzhou, China, and has made a name for itself in the pharmaceutical industry by offering a diverse range of healthcare solutions, especially for viral infections and chronic diseases. Their efforts are particularly targeted towards innovation in the treatment of HIV and improvement of diagnostic measures for the same.
This product represents Jiangsu Aidea Pharmaceutical's venture into antiretroviral therapy, specifically designed to combat HIV. Ainuovirine tablets are part of the newer generation of HIV medications aimed at suppressing the virus and improving the quality of life for those living with HIV.
The company offers a range of products in this category:
Derived from senna leaves, these granules are used as a natural laxative. The product emphasizes Jiangsu Aidea Pharmaceutical’s dedication to offering herbal and alternative medicine options alongside their synthetic pharmaceuticals, catering to a broader range of customer needs.
Understanding the critical importance of early and precise HIV diagnosis, Jiangsu Aidea Pharmaceutical also provides diagnostic equipment and reagents. This not only complements their product line of antiretroviral drugs but also reinforces their commitment to comprehensive care in the treatment and management of HIV.